Based on the Aβ-buffering role of plasma HSA, removal of plasma Aβ via plasma exchange and replacement with therapeutic HSA were suggested for facilitation of Aβ efflux from the brain of AD patients to plasma [9]. The gene discussed is ALB; the disease is Alzheimer disease.